GTL is a well‑funded, early‑stage startup developing state‑of‑the‑art digital technologies to better understand, diagnose and treat blood cancer patients.
We have built an exceptional, small‑by‑design, interdisciplinary team to translate leading academic research into real impact on global health.
Since 2023 we have made considerable progress in developing our technology, deploying our first generation of algorithms commercially with global biopharma, and working with world‑leading academic medical centres to continue developing and validating new biomarker tools that improve patient outcomes. As a member of our small team, you will have the opportunity to help shape our journey and build on our principles of collaboration, focus, and invention.
We are looking for a Software Engineer - Platform to play a critical role in the development of the core data and software platform underpinning our AI‑enabled biom...